Is Your Student at Risk for Meningococcal Disease?

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Contact
No contact information submitted.
Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

If they are a college student, then the answer is “yes!” According to the Centers for Disease Control and Prevention (CDC), about 800-1,500 cases per year of meningococcal disease occur in the U.S.

Full Summary:

No summary paragraph submitted.

If they are a college student, then the answer is “yes!”

According to the Centers for Disease Control and Prevention (CDC), about 800-1,500 cases per year of meningococcal disease occur in the U.S. Many of you have probably heard of the meningococcal outbreaks on various college campuses over the last few years, but what you may not realize is that most of these outbreaks were caused by meningococcus serogroup B. The traditional meningococcal vaccine (MCV4) does not cover serogroup B, only serogroups A, C, Y, and W135. The CDC estimates that 1 out of every 3 invasive meningococcal cases is caused by serogroup B. A vaccine against meningococcal B was not readily available for use in the United States until 2015.

At Georgia Tech, students under 22 years of age are required to have had the meningococcal conjugate vaccine (MCV4), which vaccinates against meningococcal serogroups A, C, Y, and W135, after their 16th birthday. MCV4 is a great vaccine, however, it does not protect against meningococcal B, and this vaccine is not required at Georgia Tech.

As part of the Georgia Tech college community, Stamps Health Services (SHS) is committed to providing students with the best care possible. Even though the meningococcal B vaccine is not required, it is available here at SHS.

 

Below are the prices for the meningococcal B vaccinations at SHS.

Bexsero (2 dose series) $197 per dose*

Trumenba (3 dose series) $138 per dose*

 

*Prescription insurance may cover some/all of the vaccine cost.

Please feel free to contact the pharmacy staff at SHS for more information regarding your insurance coverage for the meningococcal B vaccine 404-894-1430.

Additional Information

Groups

Parent and Family Programs

Categories
No categories were selected.
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
No keywords were submitted.
Status
  • Created By: Sara Warner
  • Workflow Status: Published
  • Created On: May 2, 2017 - 1:33pm
  • Last Updated: May 2, 2017 - 1:33pm